ATKINSON EDWARD MORROW III (EVP, Chief Technical Ops. Off.) sold 12.1% of their position (2.85K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $1.38M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/19/2026ACC: 0000875320-26-000082
Officer· EVP, Chief Technical Ops. Off.
Since Feb 2026
+584.00
Net shares
Net buyer
$2.12M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
4.96K acquired · 4.38K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+4.96K
Price / share
—
Trade value
—
% of position
24.6%
2/17/2026
20.14K→25.11K
Common Stock
Direct
Shares
−1.53K
Price / share
$483.75
Trade value
$740.14K
% of position
6.1%
2/17/2026
25.11K→23.57K
Common Stock
Direct
Shares
−2.03K
Price / share
$489.46
Trade value
$994.09K
% of position
8.6%
2/17/2026
23.57K→21.54K
Common Stock
Direct
Shares
−817.00
Price / share
$473.68
Trade value
$387K
% of position
3.8%
2/18/2026
21.54K→20.73K
Total
Net shares
+584.00
Net value
-$2.12M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | A · Award | +4.96K | — | — | 24.6% | 20.14K | 25.11K |
| Common Stock Direct | 2/17/2026 | F · Tax Withholding | −1.53K | $483.75 | $740.14K | 6.1% | 25.11K | 23.57K |
| Common Stock Direct | 2/17/2026 | S · Sale | −2.03K | $489.46 | $994.09K | 8.6% | 23.57K | 21.54K |
| Common Stock Direct | 2/18/2026 | S · Sale | −817.00 | $473.68 | $387K | 3.8% | 21.54K | 20.73K |
| Total | +584.00 | -$2.12M | ||||||
Derivative Transactions0
No derivative transactions reported